| Entry |
|
|---|
| Name |
Nartograstim (genetical recombination) (JP16);
Nartograstim (INN)
|
|---|
| Formula |
C850H1344N226O245S8
|
|---|
| Exact mass |
18893.7422
|
|---|
| Mol weight |
18905.6536
|
|---|
| Activity |
Hematopoietic stimulant [DS: H00100]
|
|---|
| Remark |
|
|---|
| Comment |
|
|---|
| Target |
granulocyte colony stimulating factor (G-CSF) receptor agonist [HSA: 1441] [KO: K05061] |
|---|
| Pathway |
hsa04060 Cytokine-cytokine receptor interaction
hsa04630 Jak-STAT signaling pathway | |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
339 Miscellaneous
3399 Others
D03245 Nartograstim (genetical recombination) (JP16); Nartograstim (INN)
Target-based classification of drugs [BR:br08310]
Cytokine receptors
Class I cytokine receptors (hematopoietin family receptors)
granulocyte colony stimulating factor (G-CSF) receptor [HSA:1441] [KO:K05061]
Nartograstim
D03245 Nartograstim (genetical recombination) (JAN); Nartograstim (INN)
 |
|---|
| Other DBs |
CAS: 134088-74-7 PubChem: NIKKAJI: |
|---|
